Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (191-200 of 304) with videos related to

Pageof 31
Sort By:
The New England Journal of Medicine|December 4, 2014
Targeting APOC3 in the familial chylomicronemia syndromeDaniel Gaudet, Diane Brisson, Karine Tremblay, et al.
Journal of Clinical Lipidology|April 26, 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trialJoseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2019
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR ActivityPoulabi Banerjee, Kuo-Chen Chan, Michel Tarabocchia, et al.
American Journal of Hypertension|January 2, 2021
SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and SmokingPavel Hamet, Zdenka Pausova, Redha Attaoua, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French CanadiansZdenka Pausova, Catriona Syme, Michal Abrahamowicz, et al.
The New England Journal of Medicine|November 16, 2020
Evinacumab in Patients with Refractory HypercholesterolemiaRobert S Rosenson, Lesley J Burgess, Christoph F Ebenbichler, et al.
American Journal of Preventive Cardiology|April 17, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Journal of Clinical Lipidology|May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French CanadiansOndrej Seda, Johanne Tremblay, Daniel Gaudet, et al.
American Journal of Human Genetics|June 15, 2006
Comprehensive association testing of common mitochondrial DNA variation in metabolic diseaseRicha Saxena, Paul I W de Bakker, Karyn Singer, et al.
Pageof 31

Showing results (191-200 of 304) with videos related to

Sort By:
Pageof 31
The New England Journal of Medicine|December 4, 2014
Targeting APOC3 in the familial chylomicronemia syndromeDaniel Gaudet, Diane Brisson, Karine Tremblay, et al.
Journal of Clinical Lipidology|April 26, 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trialJoseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2019
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR ActivityPoulabi Banerjee, Kuo-Chen Chan, Michel Tarabocchia, et al.
American Journal of Hypertension|January 2, 2021
SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and SmokingPavel Hamet, Zdenka Pausova, Redha Attaoua, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French CanadiansZdenka Pausova, Catriona Syme, Michal Abrahamowicz, et al.
The New England Journal of Medicine|November 16, 2020
Evinacumab in Patients with Refractory HypercholesterolemiaRobert S Rosenson, Lesley J Burgess, Christoph F Ebenbichler, et al.
American Journal of Preventive Cardiology|April 17, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Journal of Clinical Lipidology|May 13, 2025
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive CardiologySeyedmohammad Saadatagah, Miriam Larouche, Mohammadreza Naderian, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2008
Systematic, genome-wide, sex-specific linkage of cardiovascular traits in French CanadiansOndrej Seda, Johanne Tremblay, Daniel Gaudet, et al.
American Journal of Human Genetics|June 15, 2006
Comprehensive association testing of common mitochondrial DNA variation in metabolic diseaseRicha Saxena, Paul I W de Bakker, Karyn Singer, et al.
Pageof 31